Merck Acquires Caraway Therapeutics in a Landmark $610 Million Deal
Key Highlights Merck to acquire Caraway Therapeutics, a biopharmaceutical company focusing on neurodegenerative and rare diseases, for a…
Browsing Tag
MRL Ventures Fund
2 posts
EyeBio Secures $130 Million in Extended Series A Funding, Paving the Way for Advanced Retinal Disease Therapies
Key Highlights Significant Funding Achievement: EyeBio successfully closes an extension to its Series A financing, totaling $130 million. Strategic…